Muthoot Microfin Limited announces Q2 & H1 FY27 financial results and related updates
Muthoot Microfin · Finance
Key highlights
- Board approved unaudited financial results for quarter and half year ended September 30, 2026, reviewed by statutory auditors.
- No deviation in use of funds raised via private placement of ₹1251.68 crore NCDs, USD 30 million bonds, and ₹33.57 crore commercial paper.
- Proposal to enter material related party transaction with holding company Muthoot Fincorp Limited up to ₹2,500 crore for one year, subject to shareholder approval via postal ballot.
Why it's rated major development: the year-on-year change is 263% (50% or more)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Financial Results For Quarter Ended September 30, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other financial results filings this fortnight
- Scan Steels approves results for quarter and half year ended September 30, 2026
- Hindustan Composites appoints Vinay Sarin CEO; approves Sept 2026 quarter results
- Scan Steels approves Q2 and H1 results to Sep 30, 2026 and NSE direct listing proposal
- Sula Vineyards Limited approves Q2 & H1 FY27 results and business expansion plans
- Dr. Agarwal's Health Care approves H1 FY27 results; Amar Agarwal Executive Chairman
- Dr. Agarwal's Health Care approves H1 results; Amar Agarwal seeks Executive Chairman role
Potential multibaggers · Q2 FY27
Potential multibaggers in Finance
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.